BIO International
This event attracts decision-makers from across the biotech ecosystem, including emerging biotech companies, large pharmaceutical organizations, CDMOs, CROs, investors, regulators, and technology providers. With programming focused on areas such as cell and gene therapy, AI-driven drug discovery, biomanufacturing, clinical development, and global health, BIO International is recognized as a key destination for companies looking to accelerate innovation, build partnerships, and expand their presence within the global life sciences industry.
Date: June 22-25, 2026
Location: San Diego Convention Center, San Diego, California
Booth: #5423
JOIN US!
Meet the Catalent team at BIO 2026 to learn how we help biotech and pharmaceutical companies accelerate development and bring innovative therapies to patients faster. We partner with innovators across biologics, cell and gene therapy, oral technologies, and clinical supply services to solve complex development and manufacturing challenges — supporting the therapies and breakthroughs that matter most to patients worldwide.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS!
Date/Time: 2:30pm-2:40pm PT, Tuesday, June 23, 2026
Location: BPI Theater @ BIO 2026: Insider Interview
Speaker: John Tomtishen, Global Head of Cell Therapy Field Application Scientists and Strategic Alliances
NETWORKING EVENTS!
Cocktails & Connections
Join us Tuesday, June 23 from 5:00–6:30 PM at Booth 5423 for refreshments, networking, and conversations centered on championing the missions that matter.
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
